Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Digging into the ORIGIN trial data for Vera's atacicept in treating immunoglobulin A nephropathy (IgAN)

Ticker(s): VERA

Who's the expert?

Institution: Washington Nephrology Associates

Nephrologist in private practice in Washington, DC.
Manages 20 patients with immunoglobulin A nephropathy (IgAN) and 10 patients with C3G.
Clinical focus on the infectious complications of Peritoneal Dialysis.

Interview Goal

To better understand the treatment landscape for IgAN and to get a deeper knowledge regarding the recent phase 2b Clinical data of Atacicept.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.